NDC Active Ingredient Deferoxamine Mesylate

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0078-0467Desferal Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousNovartis Pharmaceuticals CorporationHuman Prescription Drug
0409-2336Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousHospira, Inc.Human Prescription Drug
0409-2336Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousHospira, Inc.Human Prescription Drug
0409-2336Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousHospira, Inc.Human Prescription Drug
0409-2336Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousHospira, Inc.Human Prescription Drug
0409-2337Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousHospira, Inc.Human Prescription Drug
0409-2337Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousHospira, Inc.Human Prescription Drug
0409-2337Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousHospira, Inc.Human Prescription Drug
0409-2337Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousHospira, Inc.Human Prescription Drug
47781-623Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousAlvogen Inc.Human Prescription Drug
47781-624Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousAlvogen Inc.Human Prescription Drug
52609-4504Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; IntravenousApopharma Usa, Inc.Human Prescription Drug
52609-4505Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousApopharma Usa, Inc.Human Prescription Drug
63323-597Deferoxamine Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousFresenius Kabi Usa, LlcHuman Prescription Drug
63323-599Deferoxamine Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousFresenius Kabi Usa, LlcHuman Prescription Drug
68083-172Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousGland Pharma LimitedHuman Prescription Drug
68083-173Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; IntravenousGland Pharma LimitedHuman Prescription Drug

There are 17 NDC products with the active ingredient DEFEROXAMINE MESYLATE.